Remove 2012 Remove Chemotherapy Remove Immunization
article thumbnail

Transforming oncology with antibody therapeutics

European Pharmaceutical Review

Amivantamab was the first bispecific monoclonal antibody (BsMAb) approved in the EU to treat advanced NSCLC with EGFR exon 20 insertion mutations post chemotherapy. Overall, the mechanisms of action for amivantamab include ligand blocking, receptor degradation, and immune cell-mediated activity. 2012; 23(8): 6 – 9. Cancer Ther.

article thumbnail

Integrating personalised colorectal cancer vaccines into the evolving treatment landscape

Hospital Pharmacy Europe

Taking up a consultant medical oncologist post at Queen Elizabeth Hospital Birmingham (QEHB) in 2012, Dr Kunene now specialises in upper and lower GI cancers, and cancers of unknown primary. Of course, we’ve also had the advent of immune checkpoint inhibitors. In suitable cases, these are administered in combination with chemotherapy.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

What is globulin

The Checkup by Singlecare

This test helps healthcare professionals diagnose a variety of diseases, such as kidney disease, liver damage, and autoimmune disorders, and provides information about one’s immune function. g/dL and may be associated with infections, certain cancers, or immune disorders. It occurs when the immune system is activated.

article thumbnail

OTC antiemetic medications: Relief for nausea and vomiting

The Checkup by Singlecare

Antihistamines work by blocking the effects of histamine , a chemical released by your body’s immune system. Antiemetics may also reduce radiation-associated or chemotherapy-induced nausea resulting from cancer treatment. Antihistamines When you think about antihistamines , allergy medications may come to mind.

Dosage 97
article thumbnail

CRISPR therapies targeting the next breakthrough in oncology

pharmaphorum

In 2012, Jennifer Doudna and Emmanuelle Charpentier published a paper in Science where they outlined isolating the components of the CRISPR-Cas9 system and demonstrated how it could be used to cut specific sites in isolated DNA. This would go some way to removing the damage that chemotherapy can do to healthy cells. The pipeline.

article thumbnail

Lymphoma Action – championing the patient voice in cell therapy

pharmaphorum

1 Every year, 19,500 people are diagnosed with lymphoma 2 – a cancer affecting a certain type of white blood cell within the immune system – and can be classed as either slow or fast growing. Now, people living with particular types of lymphoma have individualised options beyond chemotherapy for the first time.”. 2012, page 4.

article thumbnail

Methotrexate interactions to avoid

The Checkup by Singlecare

It is known as an antineoplastic (chemotherapy) agent, a disease-modifying antirheumatic drug ( DMARD ), and an immunosuppressant agent. Methotrexate has distinct mechanisms of action for its use as chemotherapy versus immunosuppression in autoimmune diseases.